Authorizes the imposition of bail for certain offenses involving the sale or possession with intent to sell of a controlled substance or a synthetic opioid.
Summary
This bill amends New York’s criminal procedure law to make bail available for certain drug offenses involving the sale or possession with intent to sell of controlled substances or synthetic opioids. Specifically, it adds a new qualifying category to the bail-eligible offenses listed in sections 510.10, 530.20, and 530.40, which govern pretrial release and bail determinations in criminal court, local criminal court, and superior court. The new category covers offenses under article 220 of the penal law when they involve sale or intent to sell, including fentanyl, fentanyl analogues, nitazene, and nitazene analogues.
Impact
The bill would change New York’s bail framework by expanding the set of offenses for which judges may impose bail or remand, rather than requiring release on recognizance or non-monetary conditions. It would affect defendants charged with certain narcotics trafficking offenses, prosecutors seeking bail eligibility, and courts applying pretrial release rules. The bill also makes conforming edits to existing language in the bail statutes, but it does not alter the underlying criminal penalties for drug offenses themselves.
Sentiment
The bill text and caption indicate a public-safety-oriented approach focused on drug trafficking and synthetic opioids, especially fentanyl-related conduct. No committee transcript or vote record is provided, so there is no documented debate or recorded vote sentiment in the materials supplied. Based on the bill’s framing, its sponsors appear to view the measure as a response to the dangers posed by opioid distribution and related drug sales.
Contention
The main point of contention is likely the bill’s expansion of bail eligibility in an area of law that has been the subject of broader bail-reform debates in New York. Supporters would likely argue that trafficking in fentanyl and similar substances warrants judicial discretion to set bail because of the public-health and public-safety risks involved. Opponents would likely argue that the bill reverses or weakens bail reform by increasing pretrial detention for drug offenses, potentially affecting defendants who are not accused of violent conduct. No specific stakeholder positions are included in the provided record.
Same As
Authorizes the imposition of bail for certain offenses involving the sale or possession with intent to sell of a controlled substance or a synthetic opioid.
Authorizes the imposition of bail for certain offenses involving the sale or possession with intent to sell of a controlled substance or a synthetic opioid.
Authorizes the imposition of bail for certain felony offenses involving the manufacture, sale, distribution, or possession with intent to sell synthetic opioids.
Authorizes the imposition of bail for certain felony offenses involving the manufacture, sale, distribution, or possession with intent to sell synthetic opioids.
Adds to the crime of criminal possession of a controlled substance in the third degree the possession, within any facility owned or operated by the state or upon school grounds, of any controlled substance or hazardous substance which has the potential to cause significant injury or death, with the intent to sell or distribute such substance.
Ensures repeat offenders qualify for bail and pre-trial detention when the principal has been convicted of one or more misdemeanor or felony offenses within the immediate preceding five years.
Adds certain psychoactive substances to the list of Schedule I controlled substances and modifies the offenses of possession of a controlled substance and delivery of a controlled substance